Latest market intelligence, industry updates, and institutional investing news from SEC filings data.
John Hess sold about $142.7M of Chevron stock across November 20-21, 2025 after the Chevron-Hess deal closed, while his latest Hess 13G still showed 8.58% beneficial ownership.
Jensen Huang sold about $6.6M of Nvidia stock across October 28-29, 2025, but the later quarter still confirmed AI demand was running hot and he still held 69.7M shares after the latest trade.
ROSENSWEIG DANIEL disclosed roughly $56K of recent CHGG buying during February 2026, putting fresh capital behind the position in the open market.
SCHELLER RICHARD H disclosed roughly $464K of recent MAZE selling across a September 2025 window, making the pattern more useful as a cadence signal than a single-trade headline.
SARVADI PAUL J disclosed roughly $564K of recent NSP selling across a September 2025 window, making the pattern more useful as a cadence signal than a single-trade headline.
Louis Berkman Investment CO disclosed roughly $248K of recent AP buying during November 2025, putting fresh capital behind the position in the open market.
SIEGALL CLAY B disclosed roughly $1.2M of recent IMNM buying during December 2025, putting fresh capital behind the position in the open market.
Lake Katrina disclosed roughly $2.3M of recent SFIX selling across a September 2025 to December 2025 window, making the pattern more useful as a cadence signal than a single-trade headline.
KOUNINIS EFSTATHIOS A sold roughly $755,764 of PEGA stock during a visible September-October 2025 liquidity window, making the pattern more useful as a cadence signal than a one-day headline.
LANSING WILLIAM J sold roughly $4.2M of FICO stock during a visible November 2025 liquidity window, making the pattern more useful as a cadence signal than a one-day headline.
Scott Farquhar and Mike Cannon-Brookes sold roughly $14.9M of Atlassian stock over the same late-January window, making the pattern look coordinated rather than incidental.
Martine Rothblatt sold roughly $8.4M of United Therapeutics stock across four December 2025 sessions, a pattern that looked more like disciplined exercise monetization than a blind exit.
Joseph Mansueto sold roughly $2.0M of Morningstar stock across two February 2026 sessions, extending a long-running founder liquidity pattern after the stock had already repriced lower from late-2025 highs.
Two VIAVI executives sold about $1.7M across late 2025 to early 2026, a period when the company was benefiting from a better demand narrative than it had a year earlier.
Four Travere insiders sold roughly $16.7M across late December through early February, a period when the stock had already been re-rated around the Filspari story.
QuidelOrtho 10% owner Jack Schuler bought more stock in January 2026, extending a buy campaign that had already put several million dollars to work while the company remained in rebuild mode.
Anthony Wood sold roughly $9M of Roku Class A shares across January and February 2026, but the bigger ownership story is that Schedule 13G still showed 12.83% beneficial ownership.
Mitchell Jacobson bought about $17.2 million of MSC Industrial stock in late 2025 after a weak operating stretch, a CFO transition, and a difficult year for the distribution business.
Randal Kirk's September-to-December Precigen selling followed a major corporate milestone: FDA approval of PAPZIMEOS, the company's first approved product in the U.S., and new long-term follow-up messaging around the platform.
Gary Smith's late-December to mid-February Form 4 tape came as Ciena talked about unprecedented AI-related demand, reported $1.43B in fiscal Q1 2026 revenue, and raised full-year guidance.